登录 注册 会员服务 联系我们

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

  • Published:2021-01 Issue: Volume:104 Page:110050
  • ISSN:0278-5846
  • Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • language:en
  • Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Fabbri Chiara,Kasper Siegfried,Zohar Joseph,Souery Daniel,Montgomery Stuart,Albani Diego,Forloni Gianluigi,Ferentinos Panagiotis,Rujescu Dan,Mendlewicz Julien,De Ronchi Diana,Riva Marco Andrea,Lewis Cathryn M.,Serretti Alessandro

Funder

Fondazione Umberto Veronesi

National Institute for Health Research

GlaxoSmithKline

Bristol-Myers Squibb

Lundbeck

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference108 articles.

1. Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacol;Abdallah;Off. Publ. Am. Coll. Neuropsychopharmacol.,2020

2. A role for matrix metalloproteases in antidepressant efficacy;Alaiyed;Front. Mol. Neurosci.,2019

3. Testosterone and depression in men;Amiaz;Curr. Opin. Endocrinol. Diabetes Obes.,2008

4. Antidepressant augmentation with anti-inflammatory agents;Andrade;J. Clin. Psychiatry,2014

5. Targeting neuroinflammation to treat Alzheimer's disease;Ardura-Fabregat;CNS Drugs,2017
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3